Considering the diagnostic value of CA125 and HE4 and the hot spot status of systemic inflammatory markers, this study retrospectively enrolled 189 EOC and 202 benign ovarian tumors to explore the diagnostic value of tumor markers combined with inflammatory markers for EOC. This evidence concerns the gene MUC16 and ovarian benign neoplasm.